Heart shock team may boost survival in severe heart failure
NCT ID NCT03378739
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether having a dedicated cardiogenic shock team helps more people survive severe heart failure or heart attack. Researchers will compare survival rates before and after the team was created, using data from up to 3,000 patients. The goal is to see if this team approach leads to better outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could show that a specialized shock team saves more lives in cardiogenic shock.
- What could go wrong
- This is an observational registry, not a controlled trial, so results may not prove cause and effect. Survival improvements could be due to other factors.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOGENIC SHOCK are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Inova Fairfax Hospital
RECRUITINGFalls Church, Virginia, 22042, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a temporary heart pump save more lives in cardiogenic shock?
- Could starting dialysis sooner save more hearts?
- A tiny probe into the heart's hidden reserve could forecast who needs a transplant
- Can a tiny heart pump Fine-Tune support for failing hearts?
- Could a key hormone be missing in septic shock?
- Could a simple filter tame the deadly inflammation of heart shock?